Category
ADC Therapy Antibody Therapy Cell & Gene Therapy Oncolytic Virotherapy Others Protein Therapy Small Molecule Vaccine
2025/12/26Flyer Antibody Therapy
A proprietary AI-powered discovery platform can accelerate the development of next-generation multi-specific antibodies, monoclonal antibodies, and nanobodies. A broad range of PCC molecules are being developed at an accelerated pace in early-stage discovery.
Protheragen's business is growing rapidly after founded in New York. Our business has evolved from the initial intermediary service to encompass segments in equity investment and program incubation.
 |
Protheragen Inc. |
 |
Quick Links |